Tirzepatide is a novel medication that is FDA-approved for the treatment of type 2 diabetes mellitus. is a cutting-edge weight loss therapy that targets multiple factors contributing to obesity, making it more effective than traditional methods. Given its potent weight loss properties, tirzepatide be used off-label for obesity treatment. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide.

It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications, and given as a once-a-week subcutaneous injectable. The FDA approved